Enliven Therapeutics
67 employees
Biotech/Pharma
Public · $140.0M
Company details
Team Size67
IndustryBiotech/Pharma
Funding
Total raised
$140.0M
Last stage
Public
Investors
Venrock Healthcare Capital Partners
Total raised
$140.0M
Last stage
Public
Investors
Sam Kintz
Co-founder of Enliven Therapeutics; previously Executive Director of Research at AbbVie and Head of Research at AbbVie Stemcentrx. Also worked at Roche Venture Fund and as a medicinal chemist at Genentech. Holds an MBA and BS in Chemistry from Stanford University.
Joe Lyssikatos
Co-founder and CSO of Enliven Therapeutics. Previously Executive Director at AbbVie, Staff Scientist at Genentech, and Senior Director at Array Biopharma. Earned a PhD in Chemistry from UC Berkeley.
Anish Patel
Co-founder and COO of Enliven Therapeutics. Holds a PharmD degree. Co-founded the company in July 2019 alongside Sam Kintz and Joe Lyssikatos.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.